Association for Innovation and Biomedical Research on Light and Image
PUBLICATION NAME
A Phase 2/3, Multicentre, Randomized, Double-Masked, 2-Year Trial of Pegaptanib Sodium for the Treatment of Diabetic Macular Edema.
CEC // Clinical Trials Centre
A Phase 2/3, Multicentre, Randomized, Double-Masked, 2-Year Trial of Pegaptanib Sodium for the Treatment of Diabetic Macular Edema.
Sultan M., Zhou D., Loftus J. et al, for the Macugen 1013 Study Group.
Ophthalmology 2011;118:1107-1118.
2011
